Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD
Borwin Bandelow, Christer Allgulander, David S. Baldwin, et al.
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 2, pp. 118-134
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders
Borwin Bandelow, Christer Allgulander, David S. Baldwin, et al.
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 2, pp. 79-117
Closed Access | Times Cited: 72
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
The definition of treatment resistance in anxiety disorders: a Delphi method‐based consensus guideline
Katharina Domschke, Patrik D. Seuling, Miriam A. Schiele, et al.
World Psychiatry (2024) Vol. 23, Iss. 1, pp. 113-123
Open Access | Times Cited: 12
Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review
Jaden Brandt, Jolene Bressi, Mê‐Linh Lê, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102507-102507
Open Access | Times Cited: 10
The Pharmacological Treatment of Obsessive-Compulsive Disorder
Christopher Pittenger
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 1, pp. 107-119
Closed Access | Times Cited: 17
Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases
Hubertus Himmerich, Jessica Bentley, Susan L. McElroy
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 697-718
Closed Access | Times Cited: 5
N-acetylcysteine: An Innovative Approach to Obsessive-Compulsive Disorder Treatment: A Narrative Review
Sadia Binte Anwar Sonia, Muhammad Nurul Alam Siddiki, Sarmin Sultana, et al.
Advances in Human Biology (2025)
Open Access
The Relationship between OCD and Depression in Adults: A Review of Recent Findings
Martin Pastre, Stéphane Raffard, Luc Mallet, et al.
Current Psychiatry Reports (2025)
Closed Access
Prescribing in Children and Adolescents

(2025), pp. 561-626
Closed Access
Psychotherapeutic and pharmacological agents for post-traumatic stress disorder with sleep disorder: network meta-analysis
Cheng-Yang Huang, Yifan Zhao, Zhixin Zhang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 4
The impact of psychiatric comorbidities associated with depression: a literature review
Rita Ioana Platona, Georgiana Albina Căiță, Florica Voiţă-Mekereş, et al.
Medicine and Pharmacy Reports (2024) Vol. 97, Iss. 2, pp. 143-148
Open Access | Times Cited: 3
Efficacy and acceptability of noninvasive brain stimulation for treating posttraumatic stress disorder symptoms: A network meta‐analysis of randomized controlled trials
Ping‐Tao Tseng, Bing‐Yan Zeng, Hung‐Yu Wang, et al.
Acta Psychiatrica Scandinavica (2024) Vol. 150, Iss. 1, pp. 5-21
Closed Access | Times Cited: 3
Psychological treatment of PTSD with comorbid substance use disorder (SUD): expert recommendations of the European Society for Traumatic Stress Studies (ESTSS)
Neil P. Roberts, Annett Lotzin, Ingo Schäfer
European journal of psychotraumatology (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 8
Clinical Advances in Treatment Strategies for Obsessive-compulsive Disorder in Adults
Daeyoung Roh, Ki-Won Jang, Chan‐Hyung Kim
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 4, pp. 676-685
Open Access | Times Cited: 6
Post-traumatic stress disorder in the focus of international research: from soldier heart to ICD-11
A. V. Vasileva
S S Korsakov Journal of Neurology and Psychiatry (2022) Vol. 122, Iss. 10, pp. 72-72
Closed Access | Times Cited: 10
Newer Treatments for Mood and Anxiety Disorders
Jesse Markman, Heidi Combs
Medical Clinics of North America (2024) Vol. 108, Iss. 5, pp. 911-921
Closed Access | Times Cited: 1
BNC210: an investigational α7-nicotinic acetylcholine receptor modulator for the treatment of anxiety disorders
Elliot Hampsey, Adam M. Perkins, Allan H. Young
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 277-282
Open Access | Times Cited: 4
Posttraumatic stress disorder clinical guidelines and treatment standards: focus on the symptoms of the psychophysiological arousal
A. V. Vasileva
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 5, pp. 58-58
Closed Access | Times Cited: 1
The Physiologic Basis of Neuromodulation
Tommy J. Wilson, Ankur Butala
Advances in Psychiatry and Behavioral Health (2024) Vol. 4, Iss. 1, pp. 57-69
Closed Access | Times Cited: 1
An update from the WPA Section on Anxiety and Obsessive‐Compulsive Disorders
Naomi Fineberg, Dan J. Stein, Katharina Domschke, et al.
World Psychiatry (2024) Vol. 23, Iss. 3, pp. 456-457
Open Access | Times Cited: 1
Psychological Interventions for Pediatric Posttraumatic Stress Disorder
Thole H. Hoppen, Lena Wessarges, Marvin Jehn, et al.
JAMA Psychiatry (2024)
Closed Access | Times Cited: 1
Systematic review of studies using platelet serotonin content to assess bioeffect of serotonin reuptake inhibitors at the serotonin transporter
George M. Anderson, Isabella Bruno-Pacella
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 1-13
Closed Access | Times Cited: 6
Virtual reality technology in the treatment of anxiety – progress and future challenges
Richard Porter, Ben Beaglehole, Nilufar Baghaei
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 12, pp. 1047-1049
Open Access | Times Cited: 3
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 105-114
Open Access | Times Cited: 2
Serotonin 3 receptor antagonists for obsessive-compulsive disorder: A systematic review and pairwise meta-analysis
Shun Hamanaka, Taro Kishi, Kenji Sakuma, et al.
Journal of Psychiatric Research (2023) Vol. 167, pp. 132-138
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top